ABSTRACT
Alcadeinalpha (Alcalpha) is an evolutionarily conserved type I membrane protein expressed in neurons. We show here that Alcalpha strongly associates with kinesin light chain (K(D) approximately 4-8x10(-9) M) through a novel tryptophan- and aspartic acid-containing sequence. Alcalpha can induce kinesin-1 association with vesicles and functions as a novel cargo in axonal anterograde transport. JNK-interacting protein 1 (JIP1), an adaptor protein for kinesin-1, perturbs the transport of Alcalpha, and the kinesin-1 motor complex dissociates from Alcalpha-containing vesicles in a JIP1 concentration-dependent manner. Alcalpha-containing vesicles were transported with a velocity different from that of amyloid beta-protein precursor (APP)-containing vesicles, which are transported by the same kinesin-1 motor. Alcalpha- and APP-containing vesicles comprised mostly separate populations in axons in vivo. Interactions of Alcalpha with kinesin-1 blocked transport of APP-containing vesicles and increased beta-amyloid generation. Inappropriate interactions of Alc- and APP-containing vesicles with kinesin-1 may promote aberrant APP metabolism in Alzheimer's disease.
Subject(s)
Axonal Transport/physiology , Calcium-Binding Proteins/metabolism , Kinesins/metabolism , Membrane Proteins/metabolism , Molecular Motor Proteins/metabolism , Transport Vesicles/metabolism , Adaptor Proteins, Signal Transducing/metabolism , Amyloid beta-Protein Precursor/metabolism , Animals , Blotting, Western , Drosophila , Immunoprecipitation , Mice , Microscopy, Fluorescence , RNA, Small Interfering/genetics , Transport Vesicles/physiologyABSTRACT
The regulatory mechanisms leading to IL-20 expression during infection have not been elucidated. In the present study, we found that bacterial lipopolysaccharide (LPS) induced IL-20 expression in the primary cultured glial cells and RAW264.7 macrophage cell line. Pretreatment with protein synthesis inhibitor puromycin or cycloheximide failed to inhibit the expression of IL-20, suggesting that the expression was not dependent on de novo protein synthesis. Myeloid differentiation factor 88 (MyD88) is an important adaptor molecule for Toll-like receptor signaling. We observed complete inhibition of LPS-induced expression of IL-20 in the primary cultured glial cells prepared from MyD88-deficient mice. Furthermore, a p38 MAP kinase inhibitor, SB203580, inhibited LPS-induced expression of IL-20 mRNA. LPS-induced p38 MAP kinase phosphorylation was delayed in MyD88-deficient glial cells. Therefore, it is suggested that LPS induces IL-20 expression through MyD88-p38-dependent mechanisms. As dexamethasone inhibited LPS-induced IL-20 expression, the expression of IL-20 is regulated by a negative feedback loop mediated through glucocorticoids. Therefore, it is suggested that IL-20 may play a crucial role in inflammatory conditions in the brain.
Subject(s)
Brain/cytology , Gene Expression Regulation/drug effects , Interleukins/metabolism , Lipopolysaccharides/pharmacology , Neuroglia/drug effects , Adaptor Proteins, Signal Transducing , Animals , Animals, Newborn , Antigens, Differentiation/physiology , Blotting, Western/methods , Cells, Cultured , Cycloheximide/pharmacology , Dexamethasone/pharmacology , Dose-Response Relationship, Drug , Drug Interactions , Enzyme Inhibitors/pharmacology , Glucocorticoids/pharmacology , Imidazoles/pharmacology , Interleukins/genetics , Macrophages , Mice , Mice, Inbred C57BL , Mice, Knockout , Myeloid Differentiation Factor 88 , Neuroglia/metabolism , Nitric Oxide Synthase/metabolism , Nitric Oxide Synthase Type II , Protein Synthesis Inhibitors/pharmacology , Puromycin/pharmacology , Pyridines/pharmacology , RNA, Messenger/biosynthesis , Receptors, Immunologic/deficiency , Receptors, Immunologic/physiology , Reverse Transcriptase Polymerase Chain Reaction/methods , p38 Mitogen-Activated Protein Kinases/metabolismABSTRACT
The Alcadeins (Alcs)/calsyntenins and the amyloid beta-protein precursor (APP) associate with each other in the brain by binding via their cytoplasmic domains to X11L (the X11-like protein). We previously reported that the formation of this APP-X11L-Alc tripartite complex suppresses the metabolic cleavages of APP. We show here that the metabolism of the Alcs markedly resembles that of APP. The Alcs are subjected to a primary cleavage event that releases their extracellular domain. Alcs then undergo a secondary presenilin-dependent gamma-cleavage that leads to the secretion of the amyloid beta-protein-like peptide and the liberation of an intracellular domain fragment (AlcICD). However, when Alc is in the tripartite complex, it escapes from these cleavages, as does APP. We also found that AlcICD suppressed the FE65-dependent gene transactivation activity of the APP intracellular domain fragment, probably because AlcICD competes with the APP intracellular domain fragment for binding to FE65. We propose that the Alcs and APP are coordinately metabolized in neurons and that their cleaved cytoplasmic fragments are reciprocally involved in the regulation of FE65-dependent gene transactivation. Any imbalance in the metabolism of Alcs and APP may influence the FE65-dependent gene transactivation, which together with increased secretion of amyloid beta-protein may contribute to neural disorders.
Subject(s)
Amyloid beta-Protein Precursor/chemistry , Gene Expression Regulation , Membrane Proteins/chemistry , Membrane Proteins/metabolism , Nerve Tissue Proteins/metabolism , Nuclear Proteins/metabolism , Transcriptional Activation , Amyloid Precursor Protein Secretases , Amyloid beta-Protein Precursor/metabolism , Aspartic Acid Endopeptidases , Blotting, Western , Brain/metabolism , Cell Line , Culture Media/metabolism , Cytoplasm/metabolism , DNA, Complementary/metabolism , Down-Regulation , Endopeptidases/metabolism , Humans , Models, Biological , Models, Genetic , Neurons/metabolism , Plasmids/metabolism , Protein Binding , Protein Sorting Signals , Protein Structure, Tertiary , TransfectionABSTRACT
Leptin is an important circulating signal for the regulation of food intake and body weight. Glucocorticoids were suggested to play a physiological role in the feedback inhibition of immune/inflammatory responses. In the present study, we examined whether these neuroendocrine effects of glucocorticoids are linked to changes in the leptin-induced expression of IL-1beta and STAT3 activation in the brain. Intravenous injection of leptin induced IL-1beta expression in the hypothalamus. Pretreatment with dexamethasone dose dependently inhibited leptin-induced IL-1beta expression in the hypothalamus. Moreover, dexamethasone inhibited leptin-induced IL-1beta expression in the primary cultured glial cells. In contrast, pretreatment with dexamethasone did not inhibit leptin-induced STAT3 phosphorylation in the hypothalamus. These effects of dexamethasone may not be due to the change in the expression level of the leptin receptor Ob-Ra and Ob-Rb isoforms. Therefore, it is suggested that glucocorticoid negatively regulates leptin-induced IL-1beta expression in the brain.
